Gene therapy platform
The platform uses a non-viral, DNA-based approach to in-vivo cell engineering, primarily focused on oncology and autoimmune diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
NanoCell Therapeutics is a privately held biotechnology company with offices in King of Prussia, Pennsylvania, and Utrecht, the Netherlands.
The company focuses its non-viral, DNA-based gene therapy platform on in-vivo cell engineering for oncology and autoimmune diseases. NanoCell works independently and with partners in its targeted disease areas.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The platform uses a non-viral, DNA-based approach to in-vivo cell engineering, primarily focused on oncology and autoimmune diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 2, 2026, September 6, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.